2 active not recruiting, 1 not yet recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Resectable Undifferentiated Pleomorphic Sarcoma: new trials by email Literature Review of Resectable Undifferentiated Pleomorphic Sarcoma trials Research Report on Resectable Undifferentiated Pleomorphic Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall Biospecimen Collection, Computed Tomography, Doxorubicin - Resectable Liposarcoma, Resectable Soft Tissue Sarcoma | Phase 3 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 228 | 2026-12-01 | 2026-09-16 |
| Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma Definitive Surgical Resection, Nanoplexed Poly I:C BO-112, Nivolumab - Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 14 | 2020-10-14 | 2026-03-10 |
| Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery Ipilimumab, Nivolumab, Radiation Therapy - Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 32 | 2017-10-04 | 2026-09-14 |
Histiocytoma, Malignant Fibrous (2) · Dermatofibrosarcoma (1) · Leiomyosarcoma (1) · Liposarcoma (1) · Neurofibrosarcoma (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Histiocytoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Fibrous Tissue (2) · Fibrosarcoma (1) · Neoplasms, Adipose Tissue (1) · Neoplasms, Muscle Tissue (1) · Neoplasms, Nerve Tissue (1) · Nerve Sheath Neoplasms (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurofibroma (1) · Neuromuscular Diseases (1)
Nivolumab (2) · Radiation (2) · Radiotherapy (2) · BO-112 (1) · CTLA-4 Antigen (1) · Doxorubicin (1) · Ifosfamide (1) · Ipilimumab (1) · Magnetic Resonance Spectroscopy (1) · Radiotherapy, Intensity-Modulated (1) · Specimen Handling (1) · Surgical Procedures, Operative (1) · pembrolizumab (1)
Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Ohio State University Comprehensive Cancer Center (1)
United States (3)
Christina L Roland (1) · David A Liebner (1) · Vishruth Reddy, MD, PhD (1)
K08CA245181 (1)